250 related articles for article (PubMed ID: 26950168)
1. Serum albumin 'camouflage' of plant virus based nanoparticles prevents their antibody recognition and enhances pharmacokinetics.
Pitek AS; Jameson SA; Veliz FA; Shukla S; Steinmetz NF
Biomaterials; 2016 May; 89():89-97. PubMed ID: 26950168
[TBL] [Abstract][Full Text] [Related]
2. Interactions Between Plant Viral Nanoparticles (VNPs) and Blood Plasma Proteins, and Their Impact on the VNP In Vivo Fates.
Pitek AS; Veliz FA; Jameson SA; Steinmetz NF
Methods Mol Biol; 2018; 1776():591-608. PubMed ID: 29869268
[TBL] [Abstract][Full Text] [Related]
3. Viral nanoparticles for in vivo tumor imaging.
Wen AM; Lee KL; Yildiz I; Bruckman MA; Shukla S; Steinmetz NF
J Vis Exp; 2012 Nov; (69):e4352. PubMed ID: 23183850
[TBL] [Abstract][Full Text] [Related]
4. Cancer Theranostic Applications of Albumin-Coated Tobacco Mosaic Virus Nanoparticles.
Pitek AS; Hu H; Shukla S; Steinmetz NF
ACS Appl Mater Interfaces; 2018 Nov; 10(46):39468-39477. PubMed ID: 30403330
[TBL] [Abstract][Full Text] [Related]
5. The Protein Corona of Plant Virus Nanoparticles Influences their Dispersion Properties, Cellular Interactions, and In Vivo Fates.
Pitek AS; Wen AM; Shukla S; Steinmetz NF
Small; 2016 Apr; 12(13):1758-69. PubMed ID: 26853911
[TBL] [Abstract][Full Text] [Related]
6. The in vivo fates of plant viral nanoparticles camouflaged using self-proteins: overcoming immune recognition.
Gulati NM; Pitek AS; Czapar AE; Stewart PL; Steinmetz NF
J Mater Chem B; 2018 Apr; 6(15):2204-2216. PubMed ID: 30294445
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in mice.
Bruckman MA; Randolph LN; VanMeter A; Hern S; Shoffstall AJ; Taurog RE; Steinmetz NF
Virology; 2014 Jan; 449():163-73. PubMed ID: 24418549
[TBL] [Abstract][Full Text] [Related]
8. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery.
Suk JS; Xu Q; Kim N; Hanes J; Ensign LM
Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):28-51. PubMed ID: 26456916
[TBL] [Abstract][Full Text] [Related]
9. Featured Article: Delivery of chemotherapeutic vcMMAE using tobacco mosaic virus nanoparticles.
Kernan DL; Wen AM; Pitek AS; Steinmetz NF
Exp Biol Med (Maywood); 2017 Aug; 242(14):1405-1411. PubMed ID: 28675044
[TBL] [Abstract][Full Text] [Related]
10. Enhancing Antibody Response against Small Molecular Hapten with Tobacco Mosaic Virus as a Polyvalent Carrier.
Zhao X; Chen L; Luckanagul JA; Zhang X; Lin Y; Wang Q
Chembiochem; 2015 Jun; 16(9):1279-83. PubMed ID: 25914312
[TBL] [Abstract][Full Text] [Related]
11. Elongated Plant Virus-Based Nanoparticles for Enhanced Delivery of Thrombolytic Therapies.
Pitek AS; Wang Y; Gulati S; Gao H; Stewart PL; Simon DI; Steinmetz NF
Mol Pharm; 2017 Nov; 14(11):3815-3823. PubMed ID: 28881141
[TBL] [Abstract][Full Text] [Related]
12. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation.
Han X; Li Z; Sun J; Luo C; Li L; Liu Y; Du Y; Qiu S; Ai X; Wu C; Lian H; He Z
J Control Release; 2015 Jan; 197():29-40. PubMed ID: 25449802
[TBL] [Abstract][Full Text] [Related]
13. Cryo-electron tomography investigation of serum albumin-camouflaged tobacco mosaic virus nanoparticles.
Gulati NM; Pitek AS; Steinmetz NF; Stewart PL
Nanoscale; 2017 Mar; 9(10):3408-3415. PubMed ID: 28112764
[TBL] [Abstract][Full Text] [Related]
14. Interface of physics and biology: engineering virus-based nanoparticles for biophotonics.
Wen AM; Infusino M; De Luca A; Kernan DL; Czapar AE; Strangi G; Steinmetz NF
Bioconjug Chem; 2015 Jan; 26(1):51-62. PubMed ID: 25541212
[TBL] [Abstract][Full Text] [Related]
15. Biobehavior in normal and tumor-bearing mice of tobacco mosaic virus.
Wu M; Shi J; Fan D; Zhou Q; Wang F; Niu Z; Huang Y
Biomacromolecules; 2013 Nov; 14(11):4032-7. PubMed ID: 24093622
[TBL] [Abstract][Full Text] [Related]
16. Drug-Loaded Plant-Virus Based Nanoparticles for Cancer Drug Delivery.
Bruckman MA; Czapar AE; Steinmetz NF
Methods Mol Biol; 2018; 1776():425-436. PubMed ID: 29869258
[TBL] [Abstract][Full Text] [Related]
17. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.
Owens DE; Peppas NA
Int J Pharm; 2006 Jan; 307(1):93-102. PubMed ID: 16303268
[TBL] [Abstract][Full Text] [Related]
18. Let There Be Light: Targeted Photodynamic Therapy Using High Aspect Ratio Plant Viral Nanoparticles.
Chariou PL; Wang L; Desai C; Park J; Robbins LK; von Recum HA; Ghiladi RA; Steinmetz NF
Macromol Biosci; 2019 May; 19(5):e1800407. PubMed ID: 30721575
[TBL] [Abstract][Full Text] [Related]
19. Smart surface coating of drug nanoparticles with cross-linkable polyethylene glycol for bio-responsive and highly efficient drug delivery.
Wei W; Zhang X; Chen X; Zhou M; Xu R; Zhang X
Nanoscale; 2016 Apr; 8(15):8118-25. PubMed ID: 27025546
[TBL] [Abstract][Full Text] [Related]
20. PEGylated human serum albumin (HSA) nanoparticles: preparation, characterization and quantification of the PEGylation extent.
Fahrländer E; Schelhaas S; Jacobs AH; Langer K
Nanotechnology; 2015 Apr; 26(14):145103. PubMed ID: 25789544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]